Does OCTREOTIDE Cause Neoplasm recurrence? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Neoplasm recurrence have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 0.1% of all adverse event reports for OCTREOTIDE.
22
Reports of Neoplasm recurrence with OCTREOTIDE
0.1%
of all OCTREOTIDE reports
3
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm recurrence From OCTREOTIDE?
Of the 22 reports, 3 (13.6%) resulted in death, 6 (27.3%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does OCTREOTIDE Cause?
Death (3,801)
Diarrhoea (3,621)
Fatigue (2,933)
Blood pressure increased (2,799)
Needle issue (2,740)
Malaise (2,737)
Pain (2,366)
Blood pressure systolic increased (2,340)
Malignant neoplasm progression (2,306)
Nausea (2,294)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which OCTREOTIDE Alternatives Have Lower Neoplasm recurrence Risk?
OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE
OCTREOTIDE vs ODEVIXIBAT
OCTREOTIDE vs OFATUMUMAB
OCTREOTIDE vs OFLOXACIN
OCTREOTIDE vs OLANZAPINE